Advanced Technologies & Treatments for Diabetes (ATTD)

🌟ATTD 2025 is bringing together the most advanced minds in diabetes care, showcasing groundbreaking developments that are set to transform the field. From using CGM as a diagnostic tool and pushing the boundaries of remote diabetes management, to breakthroughs in early detection of both Type 1 and Type 2 diabetes, every session promises cutting-edge insights. Join us in Amsterdam, where over 100 leading experts will share their pioneering research on a global stage. Explore the program here➡️ https://bit.ly/3NKj6Zr #DiabetesTech #DiabetesCare #DiabetesInnovation #T1D #T2D

📕 New #ATTD2024 Yearbook Session: Obesity, NAFLD/NASH & Diabetes. Get ready to explore the complex links between obesity, NAFLD/NASH, and diabetes in an essential #Yearbook2023 session led by Dr. Viral N. Shah. This session will dive into the latest research and evolving treatment approaches for these interconnected conditions, providing valuable insights. 🔗 Watch the free session here: https://bit.ly/3PlIKUJ #DiabetesInnovation #ATTDYearbook #DiabetesTech #DiabetesCare #DiabetesManagment

⚠️ You can still sign up for the next #ATTDJournalClub! An insightful journal club on the topic: "A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults with Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery" 📆 4th November 2024 🕜 16:00 CET 👉 Register Now: https://bit.ly/3U0cNEj Moderator: Diana Duarte, MD Speakers: Dr. Calhoun, PhD, Dr. Beck, MD, PhD and Dr. Hirsch, MD 📖 Read Article here: https://bit.ly/3NmE8gp Don't miss this opportunity to stay at the forefront of diabetes research. Secure your spot today! This event is supported by #Mannkind Corporation. #ATTD24 #UNLOKEducation #OnlineEducation #KenesEducation

Wondering how emotional recognition AI can be used in learning and development? Then we’d suggest checking out this excellent article from Kenes Group's Media and Communication Manager, Estefanía Zárate Angarita ♀, and Online Education Specialist, Nuria Fernández Roldán. We worked with Kenes Group on a module that integrates both emotional recognition and generative AI to offer a simulation where healthcare practitioners can practise delicate patient interactions. Practitioners get real-time feedback on their tone, language, and approach – giving them a chance for productive self-reflection on what they might do differently next time. Flip to pages 50-51 to check out the piece from Kenes, and be sure to have a look through the rest of the issue from Meeting Media Group which offers a nuanced look at how AI is applied in a whole host of use cases. Want to learn more about using this kind of tech to help learners practise conversations? Drop us a line! Here’s the article: https://lnkd.in/ePZvgEvQ #LearningAndDevelopment #GenerativeAI #EmotionalRecognitionAI #DiagnosticAI

Next up in the #ATTDYearbook 2023 series! 🧬Desmond A. Schatz dives into “Immune Interventions and Replacement Therapies in Type 1 Diabetes.” This insightful chapter explores the latest immune therapies and innovative replacement strategies, paving the way for a new era in Type 1 Diabetes care. 🧪 Learn how these advancements are transforming treatment approaches and offering new solutions. 🔗 Full chapter here: https://bit.ly/3PlIKUJ #ATTD2024 #DiabetesTech #DiabetesCare #DiabetesInnovations #T1D

#Stroke is a major cause of death and long-term disability worldwide. #Diabetes is associated with an increased risk of cardiovascular complications, including stroke. People with diabetes have a 1.5–2 times higher risk of stroke compared with people without diabetes, with risk increasing with diabetes duration. Workshop: Tackling Cardiovascular Risk through Weight Control in T2DM 👇 https://bit.ly/3BkrKL5 This is a #CME/#CPD accredited activity. Number of credits: 1 Supported by #NovoNordisk A/S. #ATTD24 #UNLOKEducation #OnlineEducation #KenesEducation

Secure your spot before registration rates increase! ⏰Today is the final day to register at regular rates for #ATTDASIA24, taking place in Singapore from 18-20 November. ⭐ Take the chance to deepen your expertise in cutting-edge diabetes care, connect with a global network of professionals and researchers, enhance your practice with insights on the latest breakthroughs, and earn up to 10.5 European CME credits. 🔗 Register now: https://bit.ly/43UA26A #DiabetesTech #DiabetesManagment #DiabetesInnovation #T1D #T2D

🚨 Change the diabetes field with your research! 📣 Late-breaking abstract submission for #ATTD2025 in Amsterdam is now open! This is your opportunity to make a real impact by advancing the latest technologies and treatments. Boost your reputation, get invaluable feedback, and connect with leaders in the diabetes community. 📚 Plus, all accepted abstracts will be featured in the renowned Diabetes Technology & Therapeutics (DTT) journal. 🗓️ Deadline: 11 November 2024 🔗 Link to submit: https://bit.ly/4dZ5kN1 #DiabetesTech #DiabetesInnovation #DiabetesResearch #T1D #T2D

🌟 The Scientific Program of #ATTDASIA24 promises to deliver a wealth of knowledge, covering a wide array of cutting-edge topics from advanced glucose sensors to AI-powered decision support systems. The sessions will address the latest innovations shaping the future of diabetes care. 👉 Explore the full interactive program here: https://bit.ly/4ejcgWW #DiabetesTech #DiabetesManagment #DiabetesCare #DiabetesInnovation

🚀 Ready for another session from the #ATTDyearbook 2023 series? Alon Liberman takes the stage with "Diabetes Technology and the Human Factor," a deep dive into how the human touch enhances the effectiveness of cutting-edge diabetes tech. 🔬 Uncover the power of innovation paired with human insight, and how this synergy is transforming diabetes care. 🔗 The full session here: https://bit.ly/3PlIKUJ #ATTD2024 #DiabetesTech #DiabetesCare #DiabetesInnovations